TITLE

IMPROVEMENT OF DYSPEPTIC SYMPTOMS AND QUALITY OF LIFE INHEALTHY INDIVIDUALS AFTER ADMINISTRATION OF ARTICHOKE LEAF EXTRACT (ALE)

AUTHOR(S)
Marakis, G.; Walker, A.; Booth, J.C.L.; Wright, J.
PUB. DATE
April 2003
SOURCE
Gut;Apr2003 Supplement 1, Vol. 52, pA81
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Background: Dyspepsia is a common condition but can be a difficult symptom to treat although antacids or pro-kinetics are often used. Recent data from Germany suggest that high doses of artichoke leaf extract (ALE) can reduce symptoms of dyspepsia. Aim: To investigate the efficacy of Iow dose intervent on with ALE on amelioration of dyspeptic symptoms and improvement of quality of life. Design of Study: Open, dose ranging postal study in patients with self-reported dyspepsia recruited through the media (articles in local and national newspapers). Methods: The Nepean Dyspepsia Index and the State-Trait Anxiety were assessed at baseline and alter 2 months of treatment with ALE to assess the efficacy of the intervention. Volunteers were randomly allocated to receive either 320 or 640 mg of the extract daily. Results: Of the 516 participants, 454 completed the study. In both dosage groups, there was a significant reduction of all dyspeptic symptoms, with an average reduction of 40% in global dyspepsia score. There were no differences in the outcome measures between the two groups. Health related quality of life was significantly improved in both groups. Conclusion: This open study demonstrated that ALE may ameliorate upper gastrointestinal symptoms and improve quality of life in healthy subjects suffering from dyspepsia. Further double blind, placebo controlled studies are needed to confirm these results. Nevertheless, these results hold promise of a safe new approach to dyspepsia in primary health care.
ACCESSION #
9747828

 

Related Articles

  • Sodium content and neutralising capacity of some commonly used antacids. Barry, R.E.; Ford, J. // British Medical Journal;2/18/78, Vol. 1 Issue 6110, p413 

    Patients suffering from hepatic failure, renal failure, and occasionally heart failure may require treatment regimens needing strict control of sodium intake. The incidence of dyspeptic symptoms in these conditions is high so that they are frequently treated concomitantly with antacids. Some...

  • Management of Acid-Related Dyspepsia in General Practice: Cost-Effectiveness Analysis Comparing an Omeprazole vs an Antacid-Alginate/Ranitidine Management Strategy. Mason, I.; Marchant, N.J. // Clinical Drug Investigation;1999, Vol. 18 Issue 2, p117 

    Objective: The objective of this study was to assess the relative cost effectiveness of an omeprazole strategy versus an antacid-alginate/ranitidine strategy for the management of acid-related dyspepsia in general practice from a third-party payer perspective. Patients and Methods: A...

  • Plop, plop, fizz, fizz . Bryan, Jenny // Vegetarian Times;Dec2002, Issue 304, p83 

    Presents advice on dealing with indigestion. Effects of indigestion; Causes of indigestion; Details on the proper use of antacids; Information on several herbal remedies.

  • GORD. Cooper, Alun // Update;10/16/2003, Vol. 67 Issue 8, p456 

    Gastro-oesophageal reflux disease (GORD) is defined as symptoms, or mucosal damage (oesophagitis), resulting from the exposure of the distal oesophagus to refluxed gastric contents. GORD accounts for 15-20% of cases of indigestion in the adult population.¹ It is a chronic relapsing condition,...

  • Heartburn.  // Consumer Reports;Sep2002, Vol. 67 Issue 9, p42 

    Offers consumer advice on heartburn relief products. Marketing strategies for antacids; Distinguishing between heartburn and other ailments; Causes; Chronic heartburn; Types of drugs available, including antacids, H[sub2] blockers and others; Ratings.

  • Step up vs step down.  // Primary Care Reports;Mar2009 Pharmacology Watch, p2 

    The article reports on a study from the Netherlands which compared the effectiveness of two therapeutic approaches for dyspepsia, particularly starting with aggressive therapy and tapering down and starting with antacids and progressing to more aggressive therapy depending on symptoms. During...

  • A Critical Look at the Clinical Use of Antacids in Acid-Peptic Disease and Gastric Acid Rebound. Texter Jr., E. Clinton // American Journal of Gastroenterology;Feb1989, Vol. 84 Issue 2, p97 

    Ancient man found that he could relieve dyspepsia by ingesting minerals that had antacid properties. Calcium carbonate was one of the first of these, as it occurred in relatively pure form in coral and limestone. Antacids were the keystone of medical management until the modern era of ulcer...

  • Health-Behavior Induced Disease: Return of the Milk-Alkali Syndrome. Caruso, Joseph B.; Pate, Rajendrakumar M.; Julka, Karan; Parish, David C. // JGIM: Journal of General Internal Medicine;Jul2007, Vol. 22 Issue 7, p1053 

    The milk-alkali syndrome is a well-documented consequence of excessive calcium and alkali intake first recognized in association with early 20th century antacid regimens. The syndrome became rare after widespread implementation of modern peptic ulcer disease therapies. With recent trends in...

  • Esophageal Hypersensitivity May Be a Major Cause of Heartburn. Rodriguez-Stanley, Sheila; Robinson, Malcolm; Earnest, David L.; Greenwood-Van Meerveld, Beverley; Miner Jr., Philip B. // American Journal of Gastroenterology;Mar1999, Vol. 94 Issue 3, p628 

    OBJECTIVE: Little is known about esophageal nociceptive thresholds in chronic heartburn sufferers with normal clinical findings. The aim of this study was to evaluate and to characterize the pathogenesis of heartburn in subjects who chronically use antacids and had not sought medical attention....

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sign out of this library

Other Topics